Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Intercept Pharmaceuticals

Clinical trials sponsored by Intercept Pharmaceuticals, explained in plain language.

Completed 1 Terminated 3

New drug duo tested to fight back against rare liver disease

Disease control Completed

This study tested whether adding a new drug called bezafibrate to an existing one (obeticholic acid) could better control Primary Biliary Changitis (PBC), a chronic liver disease. It involved 72 adults with PBC who were already on standard treatment. The main goal was to see if t…

Phase: PHASE2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC